-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*Only for medical professionals to read for reference to prevent and control stroke, blood pressure is the last word, the new mechanism of blood pressure drug ARNI is here! The blood pressure control strategy for stroke patients has always been a clinical hotspot.
How will reducing blood pressure help to prevent and control stroke? How will the launch of new antihypertensive drugs change clinical practice? On October 14 and October 20, 2021, under the auspices of Professor Chen Kangning from the Southwest Hospital of the Army Military Medical University and Professor Tan Lan from Qingdao Municipal Hospital, many experts in the field of neurology discussed angiotensin on the blood pressure needs of patients with the disease.
Receptor Enkephalinase Inhibitor (ARNI)-the approval of the indication for sacubitril and valsartan for hypertension has brought changes to patients in Shennei
.
ARNI is coming, are you ready?